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Purpose: To present the technique of a modified deep sclerectomy, which we will call “reversed” 
deep sclerectomy (RDS) and the results and our observations of its use in patients with open 
angle glaucoma (OAG) and with or without cataract extraction (phacoemulsification).
Materials and methods: This prospective study included 132 eyes which underwent RDS: 
37 eyes (group A) with uncontrolled OAG and 95 eyes (group B) with OAG and visually sig-
nificant cataract. Mean pressure preoperatively for group A was 24.48 ± 4.92 mmHg and for 
group B was 22.99 ± 3.00. The mean number of antiglaucoma drugs received was 2.97 ± 0.69 
and 2.56 ± 0.73 for groups A and B respectively. The RDS was performed where the deep scleral 
stroma is prepared in 2 parts, folded and inserted under the lateral sides of the sclerectomy, and 
the Schlemm’s canal is opened prior to deep scleral stroma preparation. Cataract was extracted 
by phacoemulsification through the same scleral opening. The follow-up for group A was 
22.23 ± 10.18 months and for group B, 25.36 ± 10.12 months.
Results: Postoperative intraocular pressure (IOP) # 21 mmHg was achieved for group A in 
40.5% without antiglaucoma drugs and 94.6% with antiglaucoma drugs, and for group B in 66.3% 
and in 94.7% respectively. Mean IOP reduction was 7.02 ± 6.35 mmHg (28.67%, P , 0.05) for 
group A and 5.26 ± 3.72 mmHg (25.06%, P # 0.05) for group B, while mean drug reduction 
was 1.97 ± 1.09 (P , 0.01) and 2.14 ± 0.95 (P # 0.01) respectively. 5-Fluorouracil was used 
in 8 eyes of group A and in 5 eyes of group B.
Conclusion: In the follow-up time during which the two groups were under study, the RDS 
was effective with a few complications, similar to the classic deep sclerectomy using implants 
or not, with the advantage, in our opinion, of a short learning curve.
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Introduction
Deep sclerectomy (DS) is a non-penetrating, tunneling surgical procedure for the 
  treatment of open angle glaucoma (OAG) cases non-responsive to drugs. Through expe-
rience acquired in time and taking into consideration the   modifications suggested,1–10 
DS proved to be a reliable alternative to trabeculectomy.8–39 Significant disadvantages 
of DS, however, is its long learning curve.19–22,40
Psilas et al41 suggested a variation of this surgical technique called “reversed” deep 
sclerectomy (RDS), which in their opinion eliminates, in part, the above disadvantage 
of the classic DS. This RDS procedure did not remove additional tissue compared to 
classic DS. We applied the RDS alone in patients with OAG and the combined surgery 





The purpose of this study is to present the surgical 
  procedures of this technique, as well as the results and obser-
vations from its application in order to determine whether 
the RDS has similar effectiveness to classic DS.
Materials and methods
This is a prospective study that includes 132 eyes from 
114 patients who underwent RDS (143 eyes were scheduled 
to undergo RDS). All the above patients were operated con-
secutively, after obtaining their informed consent.
Of a total of 132 eyes, 37 eyes (group A) suffered from 
OAG with uncontrolled intraocular pressure (IOP), despite 
maximum glaucoma drug therapy. The remaining 95 eyes 
(group B) suffered from OAG and cataract and underwent 
RDS, in combination with phacoemulsification (phaco). 
In 56 of 95 eyes (59%) in group B, IOP preoperatively 
was #21 mmHg with glaucoma drug therapy, while in the 
remaining 39 eyes (41%), IOP did not respond to maximum 
glaucoma drug therapy. Table 1 shows the demographic 
characteristics of the patients of both groups, as well as the 
tonometry data, glaucoma drug therapy, and follow-up time. 
All patients were Greek Caucasians.
With the term “uncontrolled” OAG, we define cases where 
IOP was .21 mmHg, measured with Goldmann applanation 
tonometer, despite maximum-tolerable   glaucoma drug therapy, 
with evidence of progressing optic neuropathy and visual field 
defects. The criteria for the diagnosis of OAG were according 
to the American Academy of   Ophthalmology (Glaucoma).42 
Exclusion criteria included closed angle   glaucoma, secondary 
glaucoma, previous eye surgery, previous argon-laser trabeculo-
plasty, and young patients less than 30 years of age. Patients with 
myopia or hypermetropia greater than 3 D or astigmatism more 
than 1 D that could potentially affect our   measurements were 
also excluded. On the contrary, patients with   pseudo-exfoliation 
glaucoma were included in the study.
Preoperatively, we determined the best corrected visual 
acuity (Snellen optotype at 5 m) in all patients. We   performed 
biomicroscopy, gonioscopy, Goldmann applanation tonome-
try, static perimetry with Humphrey perimeter using program 
24–2 threshold (Humphrey Inc., San Leandro, California, 
USA), ultrasound pachymetry (Pacline; OPTICON 2000 
SPA, Rome, Italy), as well as examination of the fundus and 
optic nerve head, when possible due to cataract presence. The 
central corneal thickness was within normal range (group A: 
550.16 ± 23.6 µm and group B: 549.83 ± 27.2 µm). The blood 
pressure for all patients of both groups was controlled with 
or without drug administration.
Postoperatively, patients were examined in the first 10 days 
and up to one month following operation by the study team, 
while further examinations were performed at the Glaucoma 
Department of the University Eye Clinic or by the medical 
attendants in the patients’ area of   residence. Examination 
included best corrected visual acuity,   biomicroscopy, tonom-
etry, fundus and optic nerve head evaluation. Perimetry was 
performed every 6 months or once a year, depending on the 
severity of the case, in the University Eye Clinic.
During the RDS, we excluded eyes in both groups with 
perforation of the anterior chamber and iris prolapse or when 
it was not possible to locate the Schlemm canal after the 
superficial scleral flap preparation.
All the ophthalmologists at the follow-up examina-
tions were blinded to the fact that these patients were study 
patients.
surgical procedures of “reversed”  
deep sclerectomy
The operations in both groups were performed by one of the 
authors (PK) using retrobulbar anesthesia with a 3.0–3.5 mL 
mixture solution, consisting of xylocaine 2% without adrena-
line (1.5–2.0 mL) and naropein 10% (1.5 mL).
A 4–0 silk suture was placed to the superior rectus muscle 
of the operated eye, and then followed dissection of the con-
junctiva at the limbus at 12 o’clock and hemostasis of the 
area using diathermy. An area was then selected between 10 
and 2 o’clock, where there were no large perforating veins. 
A scleral flap of 5 mm length and 4 mm width was prepared, 
based at the limbus and with a thickness of approximately 
1/3–1/2 and full thickness of the sclera. The preparation of 
the flap was then extended, reaching 1 mm away from the 
stroma of the cornea. Using 1.8–2.0 × magnification on the 
surgical microscope, and with the aid of a thin diamond knife, 
we sought the Schlemm canal, performing, carefully, a radial 
incision at the limbus. This search took place exactly at the 
Table 1 Demographic data of 114 patients (132 eyes)
Group A Group B
number of patients 33 81
number of eyes 37 95
Males/females 21/12 40/41
Age, years, mean (sD) 69.70 (8.42) 74 (7.85)
Diagnosis of POAg, n (%) 28 (75.67) 64 (67.37)
Pseudoexfoliation, n (%) 9 (24.30) 31 (32.60)
iOP (mmhg) (preoperatively), mean (sD) 24.48 (4.92) 20.99 (3.30)
number of antiglaucoma drugs 
(preoperatively), mean (sD)
2.97 (0.69) 2.56 (0.73)
Follow-up time (postoperatively),  
(range 12–42 months), mean (sD)
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limbus, where the white sclera changes into the darker area of 
the trabeculum. Guiding sign for locating the Schlemm canal 
was the horizontal white fibers of the sclera spur that lies at the 
border line of the white sclera. Right in front of these fibers 
lies the Schlemm canal from which, after perforation, aqueous 
humor wells up. In certain cases, when the Schlemm canal is 
filled with blood, this is what wells up after perforation.
Following the location of the Schlemm canal, the radial 
incision was extended to the opposite side of the quadrangle, 
so as to divide it into two equal parts. The depth of the incision 
must not extend to the full thickness of the scleral stroma in 
order to avoid reaching the ciliary body. Two parallel incisions 
were then made, on both sides of the above incision, near 
the oblique sides of the quadrangle, extending towards the 
limbus only, so as to facilitate the preparation of the anterior 
part of the deep scleral flap. At this time we perforated the 
anterior chamber in order to cause hypotony of the eye and 
thus separate the inner and outer layer of the Schlemm canal. 
Using very thin Vannas scissors, we excised the outer layer 
of the Schlemm canal by inserting one leg of the scissors into 
the canal, from the main opening, first in one and then in the 
other side. With the aid of a triangular sponge, we detached 
the anterior segment of the scleral flap from the underlying 
trabeculum. The detachment in extended beyond Schwalbe I, 
toward Descement’s membrane, which we revealed at an area 
of about 0.5–1.0 mm.2 Using small scissors, we excised this 
anterior segment of the deep scleral stroma.
The posterior part of the deep scleral stroma was   separated 
with the aid of the diamond knife into 2 parts – petals,   leaving a 
very thin layer of sclera corresponding to the ciliary body. One 
petal was then prepared up to its middle, while the remainder 
was undermined in order to fold the latter inside. In the same 
manner we folded the other petal too. Following the folding 
of the two petals, a triangular endoscleral space was formed. 
Next, we sutured the superficial sclera flap, placing two 
10–0 sutures, at the corners of the quadrangle. A small quantity 
of viscoelastic fluid was placed under the superficial flap. The 
conjunctiva was sutured at the limbus using two 8–0 sutures.
If, during the preparation of the anterior segment of 
the deep scleral flap (towards Descement’s membrane), a 
small perforation of the trabeculo-Descement’s membrane 
was to take place, without iris prolapse, we would continue 
the operation, not taking it into account. If the perforation 
was greater and the iris prolapsed, then we would perform 
peripheral iridectomy, and then continue the remainder of the 
operation without converting it to typical trabeculectomy.
In cases where RDS must be combined with phaco 
(group B), penetration of the anterior chamber was   performed 
at the same position where the superficial flap of the RDS was 
prepared, and following the precise location of the Schlemm 
canal and the two parallel incisions on both sides of the   central 
incision in the deep scleral stroma. Afterwards,   followed 
infusion of the viscoelastic fluid in the anterior chamber, 
capsulorhexis, hydrodissection, phaco, and   aspiration of 
the remaining cortex. After insertion of the proper, folded 
intraocular lens, and without removing the   viscoelastic fluid 
from the anterior chamber, followed   opening of the Schlemm 
canal and preparation of the anterior and posterior segment 
of the deep scleral stroma, as   previously described. Prior to 
suturing the superficial scleral flap, the viscoelastic fluid was 
removed from the anterior chamber. Finally, the conjunctiva 
was sutured.
Postoperatively, patients were administered a combination 
of corticosteroids and antibiotic eye drops, 1–2 drops 3 times 
daily for a period of three weeks. During the first week, 
tropixal eye drops, 1–2 drops 3 times daily was added.
If during the follow-up examinations, an encapsulated 
bleb is formed or signs of fibrosis of the bleb are evident 
and at the same time elevation of the IOP occurs, we per-
formed subconjunctival injections of 5-fluorouracil (5-FU) 
(0.1 mL of a 50 mg/mL solution) at 6 o’clock once daily for 
5 consecutive days.
The  operations  were  considered  by  us  a  “total 
success” if IOP did not exceed 21 mmHg (#21 mmHg) 
without administrating glaucoma drugs or without 5-FU 
subconjunctival injections; a “relative success” if we achieved 
the same results with the aid of glaucoma drugs and/or 
5-FU subconjunctival injections; and a “complete failure” 
if the IOP exceeded 21 mmHg with drugs and/or 5-FU 
subconjunctival injections.
statistical analysis
Statistical analysis consisted of χ2-test for qualitative 
  parameters and t-test for quantitative parameters.
Results
A total of 143 eyes were scheduled to undergo RDS or 
combined phaco–RDS. In 9 of the 143 eyes (6.3%) occurred 
penetration of the anterior chamber and iris prolapse (3 cases 
from group A and 6 cases from group B), and were   therefore 
excluded from the study. Two more cases were also excluded 
because it was not possible to locate the Schlemm canal after 
preparing the superficial scleral flap. In these two cases, the 
operation was converted to typical trabeculectomy. On the 
contrary, we included in the study eyes that during the   operation 





iris prolapse. Such minor penetrations were observed in 10 eyes 
(7.6%); 2 cases from group A and 8 cases from group B. 
Therefore, the total of the eyes that were included in the study 
were 132 (37 cases in group A and 95 cases in group B).
The  average  follow-up  time  for  group A  was 
22.23 ± 10.18 months and for group B was 25.36 ± 10.12 months 
with minimum and maximum follow-up time for both groups 
being 12 and 45 months, respectively. Table 2 presents the 
postoperative results of our study. At the time of the last 
follow-up examination, “total success” was achieved for 
40.5% (15/37) of the eyes in group A and for 66.3% (63/95) 
of the eyes in group B. “Relative success” for group A was 
94.6% (35/37) and 94.7% (90/95) for group B. For group A, 
the mean postoperative IOP at the last follow-up examination 
was 17.46 ± 4.79 mmHg and the mean decrease in IOP was 
7.02 ± 6.35 mmHg, while for group B was 15.73 ± 2.14 mmHg 
and 5.26 ± 3.72 mmHg respectively. Figure 1 represents the 
fluctuation of the mean postoperative IOP for both groups.
The mean number of glaucoma drugs which were admin-
istrated postoperatively for each patient was 1.00 ± 0.91 drugs 
for group A and 0.43 ± 0.66 for group B, while preopera-
tively, the mean number of glaucoma drugs administrated 
was 2.97 ± 0.69 and 2.56 ± 0.73, respectively (the mean 
reduction of glaucoma drugs was for group A 1.97 ± 1.09 
and for group B, 2.14 ± 0.95) (Table 3).
Injections of 5-FU during follow-up were performed in 
8 eyes from group A and 5 eyes from group B. Seven eyes 
that were characterized as “complete failures” (2 eyes from 
group A and 5 eyes from group B) underwent a second opera-
tion: 6 eyes underwent trabeculectomy using mitomycine-C, 
with satisfying results, and 1 eye underwent Ahmed valve 
implantation (from group B).
Visual acuity for group A, for most cases, returned to 
preoperative levels 1–2 weeks after the operation. In group 
B, visual acuity reached maximum level 3–4 weeks after 
the operation.
The presence of pseudoexfoliation in group A as well in 
group B did not affect the final postoperative IOP,   regarding 
neither the amount of reduction nor the mean number of 
glaucoma drugs used postoperatively (Table 4). The only 
difference noted, was that the mean age of the patients with 
pseudoexfoliation was greater than those without.
Regarding the size of the bleb, we never noted enlarged 
blebs with cyst formation, or complications regarding 
prolonged hypotony of the bulb, or inflammation during 
follow-up. Increase in IOP during the first or second month, 
postoperatively, which could be attributed to an encapsulated 
bleb, was dealt with 5-FU injections subconjunctively (8 cases 
from group A and 5 cases from group B) (Table 2).
Goniopuncture was not applied in any case.
Regarding complications, in 5 eyes from group A we 
noted swallowing of the anterior chamber, accompanied 
by hypotony of the bulb that lasted 1–7 days (in 2 of these 
cases occurred small rupture of the trabeculo-Descement’s 
diaphragm without iris prolapse). In 2 other cases, we noted 
leakage of aqueous humor from the conjunctival incision 
at the limbus (Seidel sign). In the first case we had to place 
two 8–0 sutures, while in the second one spontaneous 
  occlusion occurred 2–3 days later with pressure dressing of 
the eye. No other complication was noted. In group B we 
noted relative swallowing of the anterior chamber for a period 
of 1–2 days in 2 eyes, small hyphema (0.5–1.0 mm) in 5 eyes, 
choroidal detachment in 1 eye, and leakage of aqueous humor 
from the conjunctival incision at the limbus (Seidel sign) in 
1 eye. In all cases spontaneous cure occurred.
In eyes with total and relative success at follow-up, the 
progression of optic nerve damage and visual field defects 
were stable in both groups.
Discussion
RDS is a classic DS which, after the formation of the 
superficial scleral flap, we open first the Schlemm canal, and 
then the anterior part of the deep scleral stroma is prepared 
and excised, while the   posterior part follows, in the manner 
that was already described in detail in the Materials and 
methods section. Locating and opening the Schlemm canal 
Table 2 Postoperative results (132 eyes of 114 patients)
Group A (37 eyes) Group B (95 eyes)
Total success 15/37 (40.5%) 63/95 (66.3%)
relative success 35/37 (94.6%) 90/95 (94.7%)
Complete failure 2/37 (5.4%) 5/95 (5.3%)
Postoperative iOP (mmhg), mean (sD) 17.46 (4.79) 15.73 (2.14)
iOP decrease (mmhg), mean (sD) 7.02 (6.35) (28.67%) 5.26 (3.72) (25.06%)
number of antiglaucoma drugs postoperatively, mean (sD) 1.0 (0.91) 0.43 (0.66)
Decrease in number of antiglaucoma drugs, mean (sD) 1.97 (1.09) 2.14 (0.95)
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becomes relatively easy after only a few cases (only in 2 
out of the total cases were we unable to locate the Schlemm 
canal). Locating it is even easier for surgeons that know 
how to perform   trabeculectomy “ab externo” of Harms and 
Danheim.43
Executing RDS in the manner described ensures certain 
location of the Schlemm canal, not risking entering the 
anterior chamber, while preparing the deep scleral flap and 
approaching the Schlemm canal. Karlen et al19 report perfora-
tion of the anterior chamber and iris prolapse in 30% of cases 
for the first 10 operations performed. Likewise, Dahan and 
Drusedau22 report perforation of the anterior chamber in 1 out 
of 3 operations during the first 6 months of performing DS.
As one may notice, in our method of operation the inner 
wall of the Schlemm canal is not removed. Some surgeons 
while performing DS, with or without the use of implant, 
remove the inner wall of the Schlemm canal, along with 
the juxtacanalicular trabeculum,4,6,22,44 while others like 
  Mermoud’s team do not.9,11–13,19,23,40,45–47 Folding and not excis-
ing part of the deep scleral stroma, in our opinion, enforces 
the depth of the endoscleral space or parathalamus.48,49 We 
do not use an implant, but we infuse a small quantity of vis-
coelastic fluid under the superficial scleral flap after suturing 
it. To facilitate the opening of the Schlemm canal, we tap the 
anterior chamber in order to cause hypotony of the orbit and 
thus avoid collapsing of the walls of the Schlemm canal. The 
same operation is performed by Stegmann, before he opens the 
Schlemm canal, during viscocanalostomy.3 We, as well as he, 
did not notice any case of malignant glaucoma after tapping 
the anterior chamber and causing hypotony of the bulb.
The postoperative results (“total success”, “relative 
  success”, “complete failure”) from group A are comparable 
to classic DS with or without implant, with the same or longer 































Figure 1 Fluctuation of mean postoperative iOP for both groups.
Abbreviations: rDs, “reversed” deep sclerectomy; phaco, phacoemulsification.
Table 3 Tonometry data and antiglaucoma drug treatment (preoperatively and postoperatively)
Preoperative Postoperative P value
Group A
iOP (mmhg), mean (sD) 24.48 (4.93) 17.46 (4.79) ,0.05
Decrease iOP (mmhg), mean (sD) 7.02 (6.35) (28.67%)
number of antiglaucoma drugs, mean (sD) 2.97 (0.69) 1.0 (0.91) ,0.01
Group B
iOP (mmhg), mean (sD) 20.99 (3.30) 15.73 (2.14) ,0.05
Decrease iOP (mmhg), mean (sD) 5.26 (3.72) (25.06%)





studies is difficult. Therefore, some authors5,9,13,19,23,40,46,47 
report complete success in 40%–70% of their cases and 
relative success in 85.0%–97.7%5,9,19,23,40,47 with mean 
  postoperative reduction of IOP at 25%–50%.9,13,23,40,46,47
The postoperative success in group B is relatively higher 
than previous studies. Gianoli et al12 report 81% relative success 
in a period of 18 months in a series of 60 eyes that underwent 
a combined operation of phaco and DS. D’Eliseo et al50 report, 
following combined operation of phaco and DS, a success rate 
of 90%, without the use of glaucoma drugs, and mean IOP 
postoperatively of 13.1 mmHg. The relatively higher success 
rate in our cases (94.7%) can be attributed, in our opinion, 
partly to the fact that 56 out of 95 eyes (59%) with glaucoma 
and cataract that were included in our study and were operated 
with combined operation of phaco and RDS, had preoperatively 
IOP , 21 mmHg while taking glaucoma medication.
Shaarawy et al47 used 5-FU in 21 of 52 cases that underwent 
DS with the use of implant. Gianoli et al12 used 5-FU in 5 of 30 
cases that underwent combined operation of phaco and DS.
Postoperative complications were few and insignifi-
cant for the outcome of the operations. The postoperative 
complications observed with our technique of DS are 
not more or greater than those of the classic technique of 
DS.5,9,11,13,15,19,23,40,47
In conclusion, we can claim that the suggested RDS is a 
classic DS, where the removal of the deep scleral stroma is 
performed reversely, meaning first, the segment anterior to the 
Schlemm canal is excised, and then the segment posterior to 
the canal, in two parts, are folded. That way, we always ensure 
opening of the Schlemm canal, and with the folding of the two 
parts of the posterior segment of the deep scleral flap the para-
thalamus is enforced, without the use of special implants.
Our postoperative results of RDS in both groups (RDS or 
combined phaco-RDS), do not fall behind those of the classic 
DS according to previous studies. Furthermore postoperative 
complications are no more or greater, while in our opinion, 
the learning curve of this technique is far shorter than that 
of the classic DS.
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